Swiss National Bank Exelixis, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Exelixis, Inc. stock. As of the latest transaction made, Swiss National Bank holds 511,700 shares of EXEL stock, worth $17.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

511,700

Previous 521,800 1.94%

Holding current value

$17.7 Million

Previous $11.7 Million 13.25%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$21.96 - $27.6 $221,796 - $278,760	-10,100 Reduced 1.94%	511,700 $13.3 Million
Q2 2024 Aug 08, 2024	SELL	$20.34 - $23.73 $624,438 - $728,511	-30,700 Reduced 5.56%	521,800 $11.7 Million
Q1 2024 May 07, 2024	SELL	$20.17 - $23.93 $246,074 - $291,946	-12,200 Reduced 2.16%	552,500 $13.1 Million
Q4 2023 Feb 06, 2024	SELL	$19.25 - $24.13 $1.53 Million - $1.92 Million	-79,500 Reduced 12.34%	564,700 $13.5 Million
Q3 2023 Nov 08, 2023	BUY	$19.04 - $22.74 $175,168 - $209,208	9,200 Added 1.45%	644,200 $14.1 Million
Q2 2023 Aug 09, 2023	SELL	$18.17 - $20.48 $1.11 Million - $1.25 Million	-61,200 Reduced 8.79%	635,000 $12.1 Million
Q1 2023 May 10, 2023	SELL	$16.3 - $19.41 $1.32 Million - $1.57 Million	-80,900 Reduced 10.41%	696,200 $13.5 Million
Q4 2022 Feb 08, 2023	BUY	$14.96 - $17.39 $246,840 - $286,935	16,500 Added 2.17%	777,100 $12.5 Million
Q3 2022 Nov 09, 2022	BUY	$15.68 - $22.27 $128,576 - $182,614	8,200 Added 1.09%	760,600 $11.9 Million
Q2 2022 Aug 09, 2022	BUY	$17.44 - $23.16 $73,248 - $97,272	4,200 Added 0.56%	752,400 $15.7 Million
Q1 2022 May 09, 2022	BUY	$17.03 - $22.67 $936,650 - $1.25 Million	55,000 Added 7.93%	748,200 $17 Million
Q4 2021 Feb 08, 2022	BUY	$15.84 - $21.88 $12,672 - $17,504	800 Added 0.12%	693,200 $12.7 Million
Q3 2021 Nov 08, 2021	BUY	$16.3 - $21.14 $76,610 - $99,358	4,700 Added 0.68%	692,400 $14.6 Million
Q2 2021 Aug 06, 2021	SELL	$17.95 - $25.56 $378,745 - $539,316	-21,100 Reduced 2.98%	687,700 $12.5 Million
Q1 2021 May 07, 2021	BUY	$20.53 - $25.22 $209,406 - $257,244	10,200 Added 1.46%	708,800 $16 Million
Q4 2020 Feb 05, 2021	BUY	$18.39 - $24.8 $66,204 - $89,280	3,600 Added 0.52%	698,600 $14 Million
Q3 2020 Nov 09, 2020	BUY	$20.67 - $26.94 $272,844 - $355,608	13,200 Added 1.94%	695,000 $17 Million
Q2 2020 Aug 05, 2020	BUY	$16.46 - $27.42 $1.52 Million - $2.54 Million	92,500 Added 15.7%	681,800 $16.2 Million
Q1 2020 May 08, 2020	BUY	$14.46 - $21.8 $135,924 - $204,920	9,400 Added 1.62%	589,300 $10.1 Million
Q4 2019 Feb 06, 2020	BUY	$15.15 - $18.89 $183,315 - $228,569	12,100 Added 2.13%	579,900 $10.2 Million
Q3 2019 Nov 12, 2019	BUY	$17.68 - $22.65 $164,424 - $210,645	9,300 Added 1.67%	567,800 $10 Million
Q2 2019 Aug 02, 2019	BUY	$18.93 - $24.75 $257,448 - $336,600	13,600 Added 2.5%	558,500 $11.9 Million
Q1 2019 May 10, 2019	BUY	$19.6 - $24.76 $350,840 - $443,204	17,900 Added 3.4%	544,900 $13 Million
Q4 2018 Feb 13, 2019	BUY	$13.65 - $21.8 $166,530 - $265,960	12,200 Added 2.37%	527,000 $10.4 Million
Q1 2018 May 04, 2018	BUY	$22.15 - $31.89 $314,530 - $452,838	14,200 Added 2.84%	514,800 $11.4 Million
Q4 2017 Feb 07, 2018	BUY	$24.23 - $30.93 $276,222 - $352,602	11,400 Added 2.33%	500,600 $15.2 Million
Q3 2017 Nov 03, 2017	BUY	$23.35 - $29.24 $11.4 Million - $14.3 Million	489,200	489,200 $11.9 Million

Others Institutions Holding EXEL

# of Institutions

500

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.2B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Exelixis, Inc. Transaction History